medigraphic.com
Instituto Nacional de Salud Pública

2018, Number 3

<< Back Next >>

salud publica mex 2018; 60 (3)

Prevalence of previously diagnosed diabetes mellitus in Mexico

Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Zárate-Rojas E, Villalpando S, Barrientos-Gutiérrez T

Language: Spanish
References: 18
Page: 224-232
PDF size: 248.87 Kb.


ABSTRACT

Objective. To compare the prevalence of previously diagnosed diabetes in 2016 with previous national surveys and to describe treatment and its complications. Materials and methods. Mexico’s national surveys Ensa 2000, Ensanut 2006, 2012 and 2016 were used. For 2016, logistic regression models and measures of central tendency and dispersion were obtained. Results. The prevalence of previously diagnosed diabetes in 2016 was 9.4%. The increase of 2.2% relative to 2012 was not significant and only observed in patients older than 60 years. While preventive measures have increased, the access to medical treatment and lifestyle has not changed. The treatment has been modified, with an increase in insulin and decrease in hypoglycaemic agents. Conclusions. Population aging, lack of screening actions and the increase in diabetes complications will lead to an increase on the burden of disease. Policy measures targeting primary and secondary prevention of diabetes are crucial.


REFERENCES

  1. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Tomo 2: La salud de los adultos. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública, 2003:99.

  2. Olaiz G, Rivera J, Shamah T, Rojas R, Villalpando S, Hernández M, Sepúlveda J (eds). Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública, 2006.

  3. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados nacionales. 2da. edición. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública, 2013.

  4. Meza R, Barrientos-Gutierrez T, Rojas-Martinez R, Reynoso-Noverón N, Palacio-Mejia LS, Lazcano-Ponce E, Hernández-Ávila M. Burden of type 2 diabetes in Mexico: Past, current and future prevalence and incidence rates. Prev Med 2015;81:445–450. https://doi.org/10.1016/j. ypmed.2015.10.015

  5. Aguilar-Salinas CA, Mehta R, Rojas R, Gómez-Pérez FJ, Olaiz G, Rull JA. Management of the metabolic syndrome as a strategy for preventing the macrovascular complications of type 2 diabetes: Controversial issues. Curr Diabetes Rev 2005;1(2):145-158. https://doi. org/10.2174/1573399054022767

  6. Rull JA, Aguilar-Salinas CA, Rojas R, Ríos-Torres JM, Gómez-Pérez FJ, Olaiz G. Epidemiology of type 2 diabetes in Mexico. Arch Med Res 2005;36(3):188-196. https://doi.org/10.1016/j.arcmed.2005.01.006

  7. Romero-Martínez M, Shamah-Levy T, Cuevas-Nasu L, Méndez Gómez- Humarán I, Gaona-Pineda EB, Gómez-Acosta LM, et al. Diseño metodológico de la Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Salud Publica Mex. 2017;59:299-305. https://doi.org/10.21149/8593

  8. United Nations-Department of Economic and Social Affairs-Population Division. World population prospects: The 2012 revision. Highlights and advance tables [monografía en internet]. Nueva York: UN, 2013 [consultado 2017 feb 20]. Disponible en: http://www.un.org/en/development/desa/ population/index.shtml

  9. Lohman T, Roche A, Martorell R. Anthropometric standarization reference manual. Champlaign, IL: Human Kinetics, 1988.

  10. Habicht J. Standardization of anthropometric methods in the field. Bol Oficina Sanit Panam 1974;76(5):375-384.

  11. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA 2015;314(10):1021-1029. https://doi.org/10.1001/jama.2015.10029

  12. Villalpando S, Rojas R, Shamah-Levy T, Ávila MA, Gaona B, De la Cruz V, et al. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population. A probabilistic survey. Salud Publica Mex 2010;52(suppl 1):S19-S26. https://doi.org/10.1590/S0036-36342010000700005

  13. Seidell JC, Halberstadt J. The global burden of obesity and the challenges of prevention. Ann Nutr Metab 2015;66(suppl 2):S7-S12. https://doi. org/10.1159/000375143

  14. Institute for Health Metrics and Evaluation. GBD compare [recurso en internet]. Seattle: University of Washington, 2017 [consultado 2017 feb 21]. Disponible en: https://vizhub.healthdata.org/gbd-compare/

  15. Maskarinec G, Erber E, Grandinetti A, Verheus M, Oum R, Hopping BN, et al. Diabetes incidence based on linkages with health plans: The multiethnic cohort. Diabetes 2009;58(8):1732-1738. https://doi.org/10.2337/ db08-1685

  16. Maty SC, Everson-Rose SA, Haan MN, Raghunathan TE, Kaplan GA. Education, income, occupation, and the 34-year incidence (1965- 99) of type 2 diabetes in the Alameda County Study. Int J Epidemiol 2005;34(6):1274-1281. https://doi.org/10.1093/ije/dyi167

  17. Gutiérrez JP, García-Saisó S, Espinoza-de la Peña R, Balandrán DA. Desigualdad en indicadores de enfermedades crónicas y su atención en adultos en México: análisis de tres encuestas de salud. Salud Publica Mex. 2016;58:666-675. https://doi.org/10.21149/spm.v58i6.7923

  18. Diario Oficial de la Federación. Norma Oficial Mexicana NOM-015- SSA2-2010, para la prevención, tratamiento y control de la diabetes mellitus. México: DOF, 2010 nov 23.




2020     |     www.medigraphic.com